Moreover, PSC treated with rGal3 secrete more pro-inflammatory cytokines, such as IL8, IL6, CXCL1, CCL2, and GM-CSF, thereby contributing to maintaining their activated state and to promoting PDA progression (Figure 1). This evidence concerns the gene CSF2 and Patent ductus arteriosus.